EGFR inhibitors - PDFSEARCH.IO - Document Search Engine

EGFR inhibitors
Results: 9

#	Item
1	ZAI Lab and Hanmi execute a license agreement to develop novel EGFR targeted therapy for lung cancer in China Shanghai, China and Seoul, Korea, 23th November 2015 – ZAI Lab Limited and Hanmi Pharm. Co., Ltd. announced Add to Reading List Source URL: www.zailaboratory.com Language: English - Date: 2015-11-24 01:50:17 Lung cancer Clinical medicine Cancer Tyrosine kinase inhibitors Boehringer Ingelheim Health T790M Protein kinase inhibitor Epidermal growth factor receptor Non-small-cell lung carcinoma Targeted therapy
2	TECHNOLOGY OFFER A COBALT-BASED STRATEGY FOR TUMOUR TARGETING OF EGFR-INHIBITORS BACKGROUND The development of receptor tyrosine-kinase inhibitors (TKIs) in recent Add to Reading List Source URL: techtransfer.univie.ac.at Language: English - Date: 2015-07-01 06:41:06 Chemistry Organic chemistry Quinazolines Cancer Amines Tyrosine kinase receptors Alkynes Erlotinib Pfizer EGFR inhibitors Epidermal growth factor receptor Tyrosine-kinase inhibitor
3	HHS Public Access Author manuscript Author Manuscript Cancer Discov. Author manuscript; available in PMC 2016 January 01. Published in final edited form as: Add to Reading List Source URL: www.ncbi.nlm.nih.gov Language: English Quinazolines Lung cancer Ethers Amines Medical signs T790M Epidermal growth factor receptor EGFR inhibitors Erlotinib Osimertinib Gefitinib Cetuximab
4	Optimization of Dosing for EGFR-Mutant Non−Small Cell Lung Cancer with Evolutionary Cancer Modeling Juliann Chmielecki, et al. Sci Transl Med 3, 90ra59 (2011); DOI: scitranslmed Add to Reading List Source URL: michorlab.dfci.harvard.edu Language: English - Date: 2011-08-23 09:57:30 Quinazolines Lung cancer Amines Tyrosine kinase receptors Ethers T790M Erlotinib EGFR inhibitors Epidermal growth factor receptor Gefitinib Afatinib Targeted therapy
5	technology offer A Cobalt-Based Strategy for Tumour Targeting by EGFR-Inhibitors Background The development of receptor tyrosine-kinase inhibitors (TKIs) in recent decades was a major step forward in cancer treatment. Ho Add to Reading List Source URL: forschung.univie.ac.at Language: English - Date: 2014-04-23 07:44:21
6	technology offer A Cobalt-Based Strategy for Tumour Targeting by EGFR-Inhibitors Background The development of receptor tyrosine-kinase inhibitors (TKIs) in recent decades was a major step forward in cancer treatment. Ho Add to Reading List Source URL: forschung.univie.ac.at Language: English - Date: 2014-04-23 07:44:21 Tyrosine kinase receptors Amines Alkynes Tyrosine-kinase inhibitor Epidermal growth factor receptor Erlotinib Protein kinase inhibitor Tyrosine kinase Chemistry Organic chemistry Quinazolines
7	QSAR based model for discriminating EGFR inhibitors and non-inhibitors using Random forest Add to Reading List Source URL: www.biologydirect.com Language: English Quinazolines Tyrosine kinase receptors Alkynes Organofluorides Epidermal growth factor receptor Erlotinib Gefitinib Fingerprint Protein kinase inhibitor Chemistry Organic chemistry Amines
8	Molecular Testing Guideline for Selection of Lung Cancer Patients for EGFR and ALK Tyrosine Kinase Inhibitors Summary of Recommendations Section I. When Should Molecular Testing of Lung Cancers Be Performed? Question 1. Add to Reading List Source URL: www.amp.org Language: English - Date: 2013-04-03 10:57:43 Lung cancer Epidermal growth factor receptor Oncogenes Alkynes Organofluorides KRAS Anaplastic lymphoma kinase Protein kinase inhibitor Targeted therapy Medicine Chemistry Oncology
9	Clinical Practice Guideline - EGFR Inhibitors and Rash Add to Reading List Source URL: www.albertahealthservices.ca Language: English - Date: 2012-06-28 14:37:13 Quinazolines Organofluorides Organochlorides Lung cancer Cetuximab Erlotinib Epidermal growth factor receptor Gefitinib Protein kinase inhibitor Chemistry Organic chemistry Amines